Microstructural changes in white matter in prodromal and clinical Parkinson’s disease
Background: Parkinson’s disease (PD) is a neurodegenerative disorder that causes distinct motor impairments (i.e., resting tremor, bradykinesia, rigidity, postural instability) and affects approximately one percent of the global population over the age of 60 years. Currently, there is no cure and di...
Main Author: | Ohlhauser, Lisa |
---|---|
Other Authors: | Gawryluk, Jodie R. |
Format: | Others |
Language: | English en |
Published: |
2018
|
Subjects: | |
Online Access: | https://dspace.library.uvic.ca//handle/1828/9801 |
Similar Items
-
Editorial: Prodromal Parkinson's Disease
by: David Crosiers, et al.
Published: (2021-01-01) -
Distinct Relationship Between Cognitive Flexibility and White Matter Integrity in Individuals at Risk of Parkinson’s Disease
by: Haidar Alzaid, et al.
Published: (2020-08-01) -
Blood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease
by: Suna Lahut, et al.
Published: (2017-05-01) -
White matter disruption at the prodromal stage of Alzheimer's disease: Relationships with hippocampal atrophy and episodic memory performance
by: Florence Rémy, et al.
Published: (2015-01-01) -
Animal Model for Prodromal Parkinson’s Disease
by: Tomoyuki Taguchi, et al.
Published: (2020-03-01)